Synopsis of recent research by authors named "Rashmi Belodu"
- Rashmi Belodu's recent research explores a range of health issues including the teratogenic effects of rolapitant, a drug used in preventing chemotherapy-induced nausea and vomiting, demonstrating significant anatomical and skeletal abnormalities in chick embryos, potentially applicable to humans
- The author has conducted a study on RT-PCR test conversion patterns in COVID-19 patients in Rajasthan, India, emphasizing the implications for discharge timelines in hospital settings as an important aspect of COVID-19 management
- Further research by Belodu has focused on the sero-prevalence of hepatitis C and B viruses in Ethiopia, highlighting associated risk factors among patients attending counseling and treatment clinics, which is critical for addressing co-morbidity issues in HIV-positive populations
